home.aspx
 
EVENTS

10th International Conference on Alternative Medicine
10TH INTERNATIONAL CONFERENCE ON ALTERNATIVE MEDICINE
August 26-27, 2019
EuroSciCon welcomes you to attend the 10th International Conference on Alternative Medicine to be held from August 26-27, 2019, London, UK. Alternative Medicine 2019 aims to gather leading educational scientists, researchers and research students to exchange & share their experiences and researc...

Pharmacoepidemiology & Therapeutic Risk Management
PHARMACOEPIDEMIOLOGY & THERAPEUTIC RISK MANAGEMENT
August 24-28, 2019
Encourage you to show your support for the excellent scientific program by providing an unrestricted grant to sustain the 2019 ICPE.

Basel Laboratory

Laboratorio Basel is a company with a strong professional profile dedicated to the development and commercialization of natural extracts and essential oils for the pharmaceutical, cosmetic, veterinary, food, agrochemical and dietary supplement industries. This specialization allows us to affirm that, through the pharmacists that integrate it, all our products go through the strictest controls that guarantee their quality. We offer the pharmaceutical, food and veterinary market our experience in the production of dry, aqueous, oily extracts, glycerolated, alcoholatures, glycolics, fluids, complex and concentrates.

RELATED NEWS


New figures from NHS Digital have revealed that pupils who have recently smoked, drunk alcohol and taken drugs are more likely to be unhappy. Specifically, 51 Percent of young people aged 11 to 15 who had recently drunk alcohol, smoked cigarettes and taken drugs reported experiencing low levels of happiness compared to 36 Percent who had recently done just one of these things, and 22% who hadn’t recently smoked, drank or taken drugs. The report, ‘Smoking, Drinking and Drug Use among ...

READ MORE

AstraZeneca is still stinging after its SGLT2 diabetes drug Farxiga was waved off by the FDA in Type 1 disease. But heres something that could ease the pain- New outcomes data showing Farxiga cut cardiovascular risks in heart failure patients with or without diabetes. In a phase 3 trial, Farxiga cut the risk of cardiovascular death or hospitalization in patients with reduced ejection fraction HFrEF, when added to standard treatments for heart failure. The data could help Farxiga score a CV risk-...

READ MORE

As the closely-watched opioid litigation in Ohio nears its first trial, Endo has struck a 10 million dollars settlement and Allergan is said to be nearing its own deal. Endo unveiled a 10 million dollars agreement Tuesday that would resolve lawsuits from Ohios Cuyahoga and Summit counties. Meanwhile, the Wall Street Journal reports Allergan is negotiating a $5 million deal with the same counties. The two counties' claims were chosen for a bellwether trial in the national opioid litigation co...

READ MORE

AbbVie has announced the US Food and Drug Administration FDA approval of Rinvoq upadacitinib for moderate to severe active rheumatoid arthritis RA. In the SELECT programme, the oral JAK inhibitor met all primary and ranked secondary endpoints across a variety of patients with moderately to severely active rheumatoid arthritis, and significantly inhibited radiographic progression even without methotrexate. The study was one of the largest registrational Phase III programs in RA with approximately...

READ MORE

Lawmakers may have left the nations capital for summer vacation, but regulators at the FDA are staying busy. The agency churned out five approvals just last week from companies large and small and five more decisions are due by months end. Three of last weeks green lights opened the way for launches worth half a billion or more in annual sales. But the week started with a couple of OKs smaller on the sales side, if still significant for the organizations that developed them. Pretomanid, a tuberc...

READ MORE

Big Pharma has been able to count on China to jack up growth for the last several years, but in the second quarter one drugmaker Pfizers Upjohn unit wasnt so fortunate. Is that an ill omen for the rest of multinational pharma? One analyst is posing the question. During the second quarter, Pfizers Upjohn established medicine business now destined to merge with Mylan plummeted 20 Percent in China, mainly because of a volume-based procurement system under testing in 11 major Chinese cities. The pro...

READ MORE

Benzer Pharmacy is proud to announce that it has joined forces with ScriptDrop, the first mobile courier application for delivering medications to patients, as part of efforts to drive down costs and improve adherence rates—especially for those who might fail to pick-up their prescriptions at the pharmacy—due to the inconvenience. According to Company Spokesperson Nicholas Potts, ScriptDrop embodies, “The first medication delivery program [of its kind] to integrate directly int...

READ MORE

Talk about the importance of being vaccinated is pretty common, but unfortunately, words don’t always translate into action for countless adults. To help compensate for the shortfall, Benzer Pharmacy is introducing MinibarRx® multi-vaccine, SMART refrigeration systems in select locations throughout its organization. Describing the reasoning behind the rollout, Tonya Shackelford, VP of Clinical Services, explained that MinibarRx offers patients safe, convenient, and easily affordable ac...

READ MORE

Benzer Pharmacy proudly announces the start of a joint initiative with OrderInsite™ to improve inventory management processes across its system, ensuring that medications are always in-stock and ready for pick-up without exception. In the words of Meghann Chilcott, Chief Technology and Marketing Officer for Benzer Pharmacy, the move is intended to produce a two-fold outcome that benefits participating  pharmacies in terms of optimizing reserves for better margins, while enhancing the ...

READ MORE

AstraZeneca has announced that Calquence acalabrutinib has been granted US Breakthrough Therapy Designation BTD for chronic lymphocytic leukaemia. The US Food and Drug Administration FDA granted the designation as a monotherapy treatment for adult patients with the disease, based on positive results from the interim analyses of the ELEVATE-TN and ASCEND Phase III clinical trials, which will serve as the foundation for regulatory submissions later this year. Together the trials showed that Calque...

READ MORE

EVENTS

10th International Conference on Alternative Medicine
10TH INTERNATIONAL CONFERENCE ON ALTERNATIVE MEDICINE
August 26-27, 2019
EuroSciCon welcomes you to attend the 10th International Conference on Alternative Medicine to be held from August 26-27, 2019, London, UK. Alternative Medicine 2019 aims to gather leading educational scientists, researchers and research students to exchange & share their experiences and researc...

Pharmacoepidemiology & Therapeutic Risk Management
PHARMACOEPIDEMIOLOGY & THERAPEUTIC RISK MANAGEMENT
August 24-28, 2019
Encourage you to show your support for the excellent scientific program by providing an unrestricted grant to sustain the 2019 ICPE.